CasLoc logo
All Cases PTAB Litigations UPC Oppositions

NATERA, INC. v. NEOGENOMICS LABORATORIES, INC.

1:23-cv-00629

Overview

Case Number 1:23-cv-00629
Filing Date 2023-07-28
Status Terminated
Termination Date 2025-09-29
Court District Court, M.D. North Carolina (ncmd)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand Both

Parties

Defendant

NEOGENOMICS LABORATORIES, INC. Operating Company

Represented By

17 Attorneys Listed

JOHN J. NOLAN

KIRKLAND & ELLIS LLP

Tel: +1 (212) 341-7591

601 LEXINGTON AVENUE, NEW YORK, NY 10022

MATTHEW ROBERT STEPHENS

MORRISON & FOERSTER

Tel: +1 (858) 720-5100

MORRISON & FOERSTER, 12531 HIGH BLUFF DR.

MATTHEW I KREEGER

MORRISON & FOERSTER

Tel: +1 (415) 268-6467
Fax: +1 (415) 268-7522

MORRISON & FOERSTER, 425 MARKET STREET

JOHN D. WOOTEN , IV

WOMBLE BOND DICKINSON (US) LLP

Tel: +1 (336) 574-8090
Fax: +1 (336) 574-4521

300 N. GREENE STREET, SUITE 1900

JACK WILLIAM HAISMAN

MORRISON & FOERSTER LLP

Tel: +1 (415) 268-7000
Fax: +1 (415) 268-7522

425 MARKET ST., SAN FRANCISCO, CA 94105-2482

HUI ZHAO

MORRISON & FOERSTER

Tel: +1 (737) 309-0700

MORRISON & FOERSTER, 300 CALORADO STREET

ERIC NIKOLAIDES

MORRISON & FOERSTER LLP

Tel: +1 (212) 336-4061

250 WEST 55TH ST., NEW YORK, NY 10019

DARALYN J. DURIE

MORRISON FOERSTER LLP

Tel: +1 (415) 268-7000
Fax: +1 (415) 268-7522

425 MARKET STREET, SAN FRANCISCO, CA 94105

CHARLES CALHOUN PROVINE

MORRISON & FOERSTER

Tel: +1 (202) 887-1500
Fax: +1 (202) 887-0763

MORRISON & FOERSTER, 2100 L STREET NW

AUGUST MELCHER

JONES DAY

Tel: +1 (415) 626-3939

JONES DAY, 555 CALIFORNIA STREET

ANNIE LEE

MORRISON & FOERSTER

Tel: +1 (415) 268-7000
Fax: +1 (415) 268-7522

MORRISON & FOERSTER, 425 MARKET STREET

AARON G. FOUNTAIN

MORRIS & FOERSTER LLP

Tel: +1 (737) 309-0700

300 COLORADO STREET, SUITE 1800

PATRICK ROBERT LYONS

KIRKLAND & ELLIS LLP

Tel: +1 (312) 862-0142

333 WOLF POINT PLAZA, CHICAGO, IL 60654

ELIZABETH RYAN

GIBSON, DUNN & CRUTCHER LLP

Tel: +1 (214) 698-3219

2001 ROSS AVENUE, SUITE 2100

EDWARD R. REINES

JONES DAY

Tel: +1 (650) 739-3939
Fax: +1 (650) 739-3900

JONES DAY, 1755 EMBARCADERO ROAD

DEREK WALTER

JONES DAY

Tel: +1 (415) 626-3939
Fax: +1 (415) 875-5700

JONES DAY, 555 CALIFORNIA STREET

JOHN F. MORROW , JR.

WOMBLE BOND DICKINSON (US) LLP

Tel: +1 (336) 721-3584
Fax: +1 (336) 733-8429

ONE WEST FOURTH STREET, WINSTON-SALEM, NC 27101

Plaintiff

NATERA, INC. Operating Company

Represented By

12 Attorneys Listed

SHANNON PRINCE

QUINN EMANUEL URQUHART & SULLIVAN, LLP

Tel: +1 (713) 221-7000

700 LOUISIANA STREET, SUITE 3900

TARA SRINIVASAN

QUINN EMANUEL URQUHART & SULLIVAN LLP

Tel: +1 (510) 378-2977

50 CALIFORNIA ST., FLOOR 22

KEVIN ALEXANDER SMITH

QUINN EMANUEL URQUHART & SULLIVAN LLP

Tel: +1 (415) 876-6600
Fax: +1 (415) 875-6700

50 CALIFORNIA ST., STE 22ND FLOOR

JOSHUA HIRAM HARRIS

QUINN EMANUEL LLP

Tel: +1 (313) 330-2338

191 N. WACKER DRIVE, CHICAGO, IL 60606

ANDREW J BRAMHALL

QUINN EMANUEL URQUHART & SULLIVAN, LLP

Tel: +1 (650) 801-5000
Fax: +1 (650) 801-5100

555 TWIN DOLPHIN DRIVE, 5TH FLOOR

ANASTASIA M. FERNANDS

QUINN EMANUEL URQUHART & SULLIVAN

Tel: +1 (917) 838-4436
Fax: +1 (212) 849-7000

QUINN EMANUEL URQUHART & SULLIVAN, 295 FIFTH AVENUE

KEVIN P.B. JOHNSON

QUINN EMANUEL URQUHART & SULLIVAN, LLP

Tel: +1 (650) 801-5000
Fax: +1 (650) 801-5100

555 TWIN DOLPHIN DRIVE, 5TH FLOOR

SANDRA HABERNY

QUINN EMANUEL

Tel: +1 (213) 443-3438
Fax: +1 (213) 443-3100

QUINN EMANUEL, 865 S. FIGUEROA STREET

CARMELLE F. ALIPIO

WILLIAMS MULLEN

Tel: +1 (919) 981-4038
Fax: +1 (919) 981-4300

WILLIAMS MULLEN, 301 FAYETTEVILLE STREET

VICTORIA MAROULIS

QUINN EMANUEL

Tel: +1 (650) 801-5000

QUINN EMANUEL, 555 TWIN DOLPHIN DR.

ROBERT VAN ARNAM

WILLIAMS MULLEN

Tel: +1 (919) 981-4055
Fax: +1 (919) 981-4300

WILLIAMS MULLEN, 301 FAYETTEVILLE STREET

ANDREW R. SHORES

WILLIAMS MULLEN

Tel: +1 (919) 981-4015

WILLIAMS MULLEN, 301 FAYETTEVILLE STREET

Court & Judges

Court

District Court, M.D. North Carolina (ncmd)

Global Patent Family Cross-Litigation Radar

CasLoc 360° Radar

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

🇺🇸
U.S. District Courts 1 proceeding
🏛️
USPTO PTAB Trials 3 proceedings
🇪🇺
Unified Patent Court (UPC) Counterparts in force
🇩🇪
European Patent Office (EPO) Counterparts in force
Parallel Proceedings Across Jurisdictions (4 found):
PTAB: 3 U.S. Courts: 1
USPTO PTAB Trial 2025-01-15
IPR2025-00455

NeoGenomics Laboratories, Inc. v. Natera, Inc.

U.S. Continuation Sibling (11319596)
Status: Discretionary Denial
USPTO PTAB Trial 2024-04-17
IPR2024-00812

NeoGenomics Laboratories, Inc. v. Natera, Inc.

Asserted Patent
Status: Terminated-Settled
USPTO PTAB Trial 2023-12-19
IPR2024-00346

NeoGenomics Laboratories, Inc. v. Natera, Inc.

U.S. Continuation Sibling (11530454)
Status: Institution Denied
U.S. District Court 2020-01-27
1:20-cv-00125

Natera, Inc. v. ArcherDX, Inc.

U.S. Family Sibling (["US10538814", "US10557172", "US10590482", "US10597708"])
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

10 Patents

There are 10 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US11530454
Detecting mutations and ploidy in chromosomal segments
Filed: 2022-05-06
Issued: 2022-12-20
Active (15.5 yrs remaining)
Expires: 2042-05-06
US11519035
Methods for simultaneous amplification of target loci
Filed: 2020-07-21
Issued: 2022-12-06
Active (13.7 yrs remaining)
Expires: 2040-07-21
US11319596
Detecting mutations and ploidy in chromosomal segments
Filed: 2019-02-28
Issued: 2022-05-03
Active (12.3 yrs remaining)
Expires: 2039-02-28
US11371100
Detecting mutations and ploidy in chromosomal segments
Filed: 2019-02-28
Issued: 2022-06-28
Active (12.3 yrs remaining)
Expires: 2039-02-28
US10179937
Detecting mutations and ploidy in chromosomal segments
Filed: 2015-04-21
Issued: 2019-01-15
Active (9.8 yrs remaining) +511d PTA
Expires: 2036-09-13

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. § 283) Active Threat

Active Threat — Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term — No obviousness-type double patenting truncation noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. Standard Maintenance Fee Schedule Tracked (3.5, 7.5, 11.5 Years).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

266

Dispositive

133

Granted

18

Denied

6

Pending / Review

160

Motions by Category

Motion for Preliminary Injunction / TRO 71 Motion to Dismiss (FRCP 12(b)(6)) 24 Procedural / Extension Motion 48 Motion to Dismiss 19 Motion to Compel Discovery 6 Claim Construction / Markman Filing 46 Motion to Strike / Sanctions 8 Motion to Stay 25 Motion for Summary Judgment (Rule 56) 17 Motion for Summary Judgment (Infringement) 2

Key Dispositive Motions & Rulings

Motion for Summary Judgment (Rule 56) Granted
MEMORANDUM OPINION AND ORDER signed by Chief/Senior District Judge CATHERINE C. EAGLES on 8/28/2025; that: The defendant's motion for summary judgment, Doc. 4...
Entry #577 • 2025-08-28 Document →
Motion for Summary Judgment (Infringement) Pending / Under Review
NOTICE by NATERA, INC. of Filing Demonstratives from Summary Judgment Hearing (Attachments: # 1 Exhibit Section 101 Slides (No Confidential Info), # 2 Exhibit I...
Entry #556 • 2025-08-15 Document →
Motion for Summary Judgment (Infringement) Pending / Under Review
SEALED UNREDACTED DOCUMENTS Notice of Filing Demonstratives from Summary Judgment Hearing filed by Plaintiff NATERA, INC., Defendant NEOGENOMICS LABORATORIES, I...
Entry #557 • 2025-08-15 Document →
Motion for Summary Judgment (Rule 56) Pending / Under Review
Minute Entry for proceedings held before Chief/Senior District Judge CATHERINE C. EAGLES: Motion Hearing held on 8/8/2025 regarding 489 MOTION for Summary Judgm...
Entry #554 • 2025-08-08 Document →
Motion for Summary Judgment (Rule 56) Pending
Motions Submitted: 489 MOTION for Summary Judgment, 494 MOTION for Summary Judgment, 496 MOTION to Exclude Testimony and Opinions of Dr. Lennon, 498 MOTION to E...
Entry #— • 2025-07-22
Motion for Summary Judgment (Rule 56) Pending / Under Review
REPLY, filed by Defendant NEOGENOMICS LABORATORIES, INC., to Response to 489 MOTION for Summary Judgment filed by NEOGENOMICS LABORATORIES, INC.. (MORROW, JOHN)...
Entry #534 • 2025-07-18 Document →

Docket Entries

(928 total)
Pleading / Complaint

COMPLAINT against Neogenomics Laboratories, Inc. ( Filing fee $ 402 receipt number ANCMDC-3618904.), filed by Natera, Inc. (Attachments: # 1 Exhibit 1. US 11530454, # 2 Exhibit 2. US 11519035, # 3 Exhibit 3. 454 Patent Claim Chart, # 4 Exhibit 4. 035 Patent Claim Chart, # 5 Exhibit 5. RaDaR Residual Disease and Recurrence, # 6 Exhibit 6. Heider AACR Virtual Poster, # 7 Exhibit 7. AACR 2020, # 8 Exhibit 8. Lipsyc Sharf, # 9 Exhibit 9. Gale, # 10 Exhibit 10. Flach, # 11 Exhibit 11. AACR 2020 Poster 3097, # 12 Exhibit 12. Cutts AACR 2021, # 13 Exhibit 13. Gale Pub, # 14 Exhibit 14. AACR 2021 Pubs, # 15 Exhibit 15. TAm-Seq Poster, # 16 Exhibit 16. Forshew, # 17 Exhibit 17. NeoGenomics Labs, # 18 Exhibit 18. CAP Certificate, # 19 Exhibit 19. CLIA Certificate, # 20 Exhibit 20. Sebastian, # 21 Exhibit 21. NeoGenomics Annual Report, # 22 Exhibit 22. RaDaR Discussion Guide, # 23 Exhibit 23. RaDaR Commercial Avail Announcement, # 24 Exhibit 24. MoIDX-DEX Diagnostics, # 25 Exhibit 25. RaDaR Assay Request Form, # 26 Exhibit 26. NeoGenomics Global Conf. Takeaways, # 27 Exhibit 27. Top Ten Article, # 28 Exhibit 28. Signatera - Innovation Award, # 29 Exhibit 29. MedTech Breakthrough winners, # 30 Exhibit 30. RaDaR Medicare Coverage Article, # 31 Civil Cover Sheet)(VAN ARNAM, ROBERT) (Entered: 07/28/2023)

Entry #1 • 2023-07-28
1
Pleading / Complaint

COMPLAINT against Neogenomics Laboratories, Inc. ( Filing fee $ 402 receipt number ANCMDC-3618904.), filed by Natera, Inc. (Attachments: # 1 Exhibit 1. US 11530454, # 2 Exhibit 2. US 11519035, # 3 Exhibit 3. 454 Patent Claim Chart, # 4 Exhibit 4. 035 Patent Claim Chart, # 5 Exhibit 5. RaDaR Residual Disease and Recurrence, # 6 Exhibit 6. Heider AACR Virtual Poster, # 7 Exhibit 7. AACR 2020, # 8 Exhibit 8. Lipsyc Sharf, # 9 Exhibit 9. Gale, # 10 Exhibit 10. Flach, # 11 Exhibit 11. AACR 2020 Poster 3097, # 12 Exhibit 12. Cutts AACR 2021, # 13 Exhibit 13. Gale Pub, # 14 Exhibit 14. AACR 2021 Pubs, # 15 Exhibit 15. TAm-Seq Poster, # 16 Exhibit 16. Forshew, # 17 Exhibit 17. NeoGenomics Labs, # 18 Exhibit 18. CAP Certificate, # 19 Exhibit 19. CLIA Certificate, # 20 Exhibit 20. Sebastian, # 21 Exhibit 21. NeoGenomics Annual Report, # 22 Exhibit 22. RaDaR Discussion Guide, # 23 Exhibit 23. RaDaR Commercial Avail Announcement, # 24 Exhibit 24. MoIDX-DEX Diagnostics, # 25 Exhibit 25. RaDaR Assay Request Form, # 26 Exhibit 26. NeoGenomics Global Conf. Takeaways, # 27 Exhibit 27. Top Ten Article, # 28 Exhibit 28. Signatera - Innovation Award, # 29 Exhibit 29. MedTech Breakthrough winners, # 30 Exhibit 30. RaDaR Medicare Coverage Article, # 31 Civil Cover Sheet)(VAN ARNAM, ROBERT) (Entered: 07/28/2023)

Entry #1 • 2023-07-28
2
Pleading / Complaint

COMPLAINT against Neogenomics Laboratories, Inc. ( Filing fee $ 402 receipt number ANCMDC-3618904.), filed by Natera, Inc. (Attachments: # 1 Exhibit 1. US 11530454, # 2 Exhibit 2. US 11519035, # 3 Exhibit 3. 454 Patent Claim Chart, # 4 Exhibit 4. 035 Patent Claim Chart, # 5 Exhibit 5. RaDaR Residual Disease and Recurrence, # 6 Exhibit 6. Heider AACR Virtual Poster, # 7 Exhibit 7. AACR 2020, # 8 Exhibit 8. Lipsyc Sharf, # 9 Exhibit 9. Gale, # 10 Exhibit 10. Flach, # 11 Exhibit 11. AACR 2020 Poster 3097, # 12 Exhibit 12. Cutts AACR 2021, # 13 Exhibit 13. Gale Pub, # 14 Exhibit 14. AACR 2021 Pubs, # 15 Exhibit 15. TAm-Seq Poster, # 16 Exhibit 16. Forshew, # 17 Exhibit 17. NeoGenomics Labs, # 18 Exhibit 18. CAP Certificate, # 19 Exhibit 19. CLIA Certificate, # 20 Exhibit 20. Sebastian, # 21 Exhibit 21. NeoGenomics Annual Report, # 22 Exhibit 22. RaDaR Discussion Guide, # 23 Exhibit 23. RaDaR Commercial Avail Announcement, # 24 Exhibit 24. MoIDX-DEX Diagnostics, # 25 Exhibit 25. RaDaR Assay Request Form, # 26 Exhibit 26. NeoGenomics Global Conf. Takeaways, # 27 Exhibit 27. Top Ten Article, # 28 Exhibit 28. Signatera - Innovation Award, # 29 Exhibit 29. MedTech Breakthrough winners, # 30 Exhibit 30. RaDaR Medicare Coverage Article, # 31 Civil Cover Sheet)(VAN ARNAM, ROBERT) (Entered: 07/28/2023)

Entry #1 • 2023-07-28
2
Pleading / Complaint

COMPLAINT against Neogenomics Laboratories, Inc. ( Filing fee $ 402 receipt number ANCMDC-3618904.), filed by Natera, Inc. (Attachments: # 1 Exhibit 1. US 11530454, # 2 Exhibit 2. US 11519035, # 3 Exhibit 3. 454 Patent Claim Chart, # 4 Exhibit 4. 035 Patent Claim Chart, # 5 Exhibit 5. RaDaR Residual Disease and Recurrence, # 6 Exhibit 6. Heider AACR Virtual Poster, # 7 Exhibit 7. AACR 2020, # 8 Exhibit 8. Lipsyc Sharf, # 9 Exhibit 9. Gale, # 10 Exhibit 10. Flach, # 11 Exhibit 11. AACR 2020 Poster 3097, # 12 Exhibit 12. Cutts AACR 2021, # 13 Exhibit 13. Gale Pub, # 14 Exhibit 14. AACR 2021 Pubs, # 15 Exhibit 15. TAm-Seq Poster, # 16 Exhibit 16. Forshew, # 17 Exhibit 17. NeoGenomics Labs, # 18 Exhibit 18. CAP Certificate, # 19 Exhibit 19. CLIA Certificate, # 20 Exhibit 20. Sebastian, # 21 Exhibit 21. NeoGenomics Annual Report, # 22 Exhibit 22. RaDaR Discussion Guide, # 23 Exhibit 23. RaDaR Commercial Avail Announcement, # 24 Exhibit 24. MoIDX-DEX Diagnostics, # 25 Exhibit 25. RaDaR Assay Request Form, # 26 Exhibit 26. NeoGenomics Global Conf. Takeaways, # 27 Exhibit 27. Top Ten Article, # 28 Exhibit 28. Signatera - Innovation Award, # 29 Exhibit 29. MedTech Breakthrough winners, # 30 Exhibit 30. RaDaR Medicare Coverage Article, # 31 Civil Cover Sheet)(VAN ARNAM, ROBERT) (Entered: 07/28/2023)

Entry #1 • 2023-07-28
2
Pleading / Complaint

COMPLAINT against Neogenomics Laboratories, Inc. ( Filing fee $ 402 receipt number ANCMDC-3618904.), filed by Natera, Inc. (Attachments: # 1 Exhibit 1. US 11530454, # 2 Exhibit 2. US 11519035, # 3 Exhibit 3. 454 Patent Claim Chart, # 4 Exhibit 4. 035 Patent Claim Chart, # 5 Exhibit 5. RaDaR Residual Disease and Recurrence, # 6 Exhibit 6. Heider AACR Virtual Poster, # 7 Exhibit 7. AACR 2020, # 8 Exhibit 8. Lipsyc Sharf, # 9 Exhibit 9. Gale, # 10 Exhibit 10. Flach, # 11 Exhibit 11. AACR 2020 Poster 3097, # 12 Exhibit 12. Cutts AACR 2021, # 13 Exhibit 13. Gale Pub, # 14 Exhibit 14. AACR 2021 Pubs, # 15 Exhibit 15. TAm-Seq Poster, # 16 Exhibit 16. Forshew, # 17 Exhibit 17. NeoGenomics Labs, # 18 Exhibit 18. CAP Certificate, # 19 Exhibit 19. CLIA Certificate, # 20 Exhibit 20. Sebastian, # 21 Exhibit 21. NeoGenomics Annual Report, # 22 Exhibit 22. RaDaR Discussion Guide, # 23 Exhibit 23. RaDaR Commercial Avail Announcement, # 24 Exhibit 24. MoIDX-DEX Diagnostics, # 25 Exhibit 25. RaDaR Assay Request Form, # 26 Exhibit 26. NeoGenomics Global Conf. Takeaways, # 27 Exhibit 27. Top Ten Article, # 28 Exhibit 28. Signatera - Innovation Award, # 29 Exhibit 29. MedTech Breakthrough winners, # 30 Exhibit 30. RaDaR Medicare Coverage Article, # 31 Civil Cover Sheet)(VAN ARNAM, ROBERT) (Entered: 07/28/2023)

Entry #1 • 2023-07-28
2

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc